As a reminder, The federal COVID-19 public health emergency is ending on May 11, 2023.
What to know about COVID-19 coverage after May 11, 2023
In California, COVID-19 vaccines, testing, and treatment (therapeutics) will continue to be provided and covered at $0 cost-share, in compliance with California law for fully insured health plans.
Kaiser Permanente® will share more details on how coverage may change as the information becomes available.
For additional details about the end of the federal COVID-19 public health emergency, visit account.kp.org.
CAA RxDC reporting terminated group outreach
In March, Kaiser contacted their current customers and brokers to request group specific information required for them to complete aggregated reports for pharmacy reporting under the Consolidated Appropriations Act (CAA), 2021. To help ensure compliance with the reporting requirements, groups were required to provide specific information via Kaiser's form by April 3, 2023.
Kaiser set the April 3rd deadline to allow groups to identify and remediate any issues with this complex process before the Centers for Medicare & Medicaid Services’ (CMS) June 1, 2023 due date. In working with the data submitted by April 3rd, Kaiser found that their original outreach inadvertently omitted groups that terminated their coverage with Kaiser Permanente prior to the original outreach. In response, Kaiser will be sending emails directly to the identified groups requesting they submit the needed information for their company by 5 p.m. PT on May 18, 2023.
To remain on track to meet the CMS submission deadline, Kaiser is only accepting data from the groups previously omitted.
“Kaiser,” “Kaiser Permanente,” “Kaiser Foundation Health Plan” and the Kaiser Permanente Logo are registered trademarks or service marks of Kaiser Foundation Health Plan, Inc., in the United States
For more Information reach to your Amwins Connect Sales Representative.